Riskpilot← Back to searchSign inGet full accessREDO BIOSOLUTIONS AS
ASActiveOrg 984238126Porselensvegen 14, 3920 PorsgrunnDistribution of gaseous fuels through mains · NACE 3522Est. 200220 employeesredobiosolutions.com
Revenue 2024
NOK 510,3M
+26% vs 2023
EBITDA margin
24.3%
+44% vs 2023
Equity ratio
74.9%
Financial strength
Net profit 2024
NOK 80,6M
+71% vs 2023
| Revenue | NOK 510,3M | +26% |
| EBITDA | NOK 123,9M | +44% |
| Net profit | NOK 80,6M | +71% |
| Total assets | NOK 639,8M | +12% |
| Equity | NOK 479,2M | +21% |
| Employees | 20 | — |
Legal name
REDO BIOSOLUTIONS AS
Org number
984238126
Legal form
Aksjeselskap
NACE code
3522 · Distribution of gaseous fuels through mains
Founded
18. januar 2002
Share capital
NOK 20 800 000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
(a) innkjøp og salg av (bio) metangass (b) investering og drift av (i) (bio) metangass, herunder produksjon, kondensering og oppgradering (ii) (bio) metangass fyllestasjoner (iii) lagringsanlegg for (bio) metangass og (iv) distribusjonsnett for (bio) metangass samt (c) markedsføring og salg av relaterte produkter.
Address
Porselensvegen 14, 3920 Porsgrunn
Phone
+4794131300
Email
firmapost@skageraknaturgass.no
Website
redobiosolutions.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 183 447 | 288 248 | 424 384 | 404 749 | 510 336 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 30 998 | 31 148 | 70 391 | 85 875 | 123 946 |
| Depreciation & amort. | −16 774 | −16 831 | −16 620 | −21 808 | −22 309 |
| EBIT | 14 224 | 14 317 | 53 771 | 64 067 | 101 637 |
| Net financials | −2 703 | −1 558 | 2 770 | −3 301 | 1 806 |
| Profit before tax | 11 522 | 12 759 | 56 541 | 60 766 | 103 443 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 9 044 | 9 943 | 43 976 | 47 220 | 80 567 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 241 878 | 307 434 | 520 751 | 569 094 | 639 845 |
| Equity | 143 277 | 154 407 | 198 329 | 397 660 | 479 229 |
| Long-term debt | 63 050 | 92 750 | 74 750 | 57 050 | 39 450 |
| Short-term debt | 32 257 | 58 403 | 246 533 | 114 384 | 121 166 |
| Total debt | 95 307 | 151 153 | 321 283 | 171 434 | 160 616 |
EBITDA margin
24.3%
This company
15.8%
Market median
+54% vs market
20202024
Equity ratio
74.9%
This company
38.2%
Market median
+96% vs market
20202024
Return on equity
16.8%
This company
18.4%
Market median
+9% vs market
20202024
Net profit margin
15.8%
This company
8.1%
Market median
+95% vs market
20202024
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FH Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2023 | |
| Board of Directors | 2021 | |
| Former (3) | ||
| Board of Directors | 2021 – 2023 | |
| Chairman | 2021 – 2023 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Air Liquide Biogas International | Company | 51% | 51% | 2024 |
| Company | 49% | 49% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
REDO BIOSOLUTIONS AS 
BIO JÆREN ASBoard members of REDO BIOSOLUTIONS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frode Halvorsen | Chief Executive Officer | 0 companies |
| Pierre-Emmanuel Jean Michel Meyer | Board of Directors | 0 companies |
| Jeremie Adrien Lallemand | Board of Directors | 0 companies |
| Alexandre Alain Demangeon | Chairman | 0 companies |
| Inger Anne Tho Bjørvik | Board of Directors | 0 companies |
| Kjetil Dahl | Board of Directors | 0 companies |
| Camilla Moe | Board of Directors | 0 companies |
| Charles-Henry Marie Rene Hubert Des Villettes | Chairman | 0 companies |
| Olivier Alain Paul Louedin | Board of Directors | 0 companies |